Constructive state utility rate regulation allows NiSource to collect a return of and a return on the bulk of its investments within 18 months, enhancing cash flow.

Here's our initial take on Vertex Pharmaceuticals' (NASDAQ: VRTX) fourth-quarter financial report. Key Metrics Metric Q4 2023 Q4 2024 Change vs. Expectations Revenue $2.52 billion $2.91 billion 16% ...

i3 Verticals, Inc. (NASDAQ: IIIV) Q1 2025 Earnings Call Transcript February 7, 2025 ...

Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Acadian Asset Management Incorporated Earnings Conference Call and Webcast for the Fourth Quarter 2024.

Pharmaceuticals giant GlaxoSmithKline (GSK) has lifted its long-term sales guidance as it hailed a strong drugs pipeline. It came as the boss of the London-listed firm cheered an “excellent” ...

In our view, FMC is at risk for a dividend cut. Should FMC not see profit growth in 2025 and 2026 as expected, the dividend may be reduced or cut alltogether. FMC pays a little less than $300 million ...

Brookfield Renewable Partners L.P. (TSX: BEP.UN; NYSE: BEP) ("Brookfield Renewable Partners”, "BEP") today reported financial results for the three and twelve months ended December 31, 2024. "2024 was ...

Want 15% off at Adore Beauty? Sign up to the latest news at Marie Claire. Delivering a big impact on both the look of your space and your sleep quality, there are few things as important as your ...

DLF clocked ₹12,093 crore of sales in the third ... a robust pipeline of new products across both development and rental business, strong balance sheet and consistent cash flow generation ...

According to InvestingPro data, the company maintains a strong financial foundation with more cash than debt on its balance sheet ... sales. Analysts express concern that Incyte's current pipeline ...

BioNTech's strong balance sheet and innovative mRNA technology ... reinforcing the hold rating amidst financial and pipeline uncertainties. This is not only a poor performance but also a ...